Hydroxyoctadecadienoic Acid (HODE) as a Marker of Linoleic Acid Oxidation

Biomarkers for Antioxidant Defense and Oxidative Damage: Principles and Practical Applications

Volumn , Issue , 2010, Pages 85-97

  Yoshida, Yasukazu ^a   Niki, Etsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Antioxidant role against lipid oxidation; Biomarker development, for oxidative stress measurement in humans; Carotenoids, well known quenchers of singlet oxygen; Free linoleic acid and its esters oxidized by three distinct mechanisms; Free radical mediated linoleate oxidation; Hydroxyoctadecadienoic Acid (HODE) as linoleic acid oxidation marker; Lipid oxidation products, HODE as biomarkers usefulness and accuracy; Plasma and erythrocytes, separated from whole blood for tHODE analyses; Polyunsaturated fatty acids susceptible to oxidation; Thiobarbituric reactive substances (TBARS), malonaldehyde (MDA), HODE, isoprostanes and oxysterols

Indexed keywords

EID: 84886300057     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813814438.ch6     Document Type: Chapter

References (44)

1. Bachi A, Zuccato E, Baraldi M, Fanelli R, Chiabrando C. 1996. Measurements of urinary 8 -epi -prostaglandin F2a, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography -mass spectrometry. Basal levels in smokers and nonsmokers, Free Rad Biol Med 20: 619-624.
2. Blumberg J. 2004. Use of biomarkers of oxidative stress in research studies. J Nutr 134: 3188S-3189S.
3. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. 2006. Biomarkers of oxidative damage in human disease. Clin Chem 52: 601-623.
4. Diczfalusy U. 2004. Analysis of cholesterol oxidation products in biological samples J AOAC Int 87: 467-473.
5. Elbekai RH, El-Kadi AOC. 2006. Cytochrome P450 enzymes: Central players in cardiovascular health and disease, Pharmacol Ther 112: 564-587.
6. Gniwotta C, Morrow JD, Roberts J, Kuhn H. 1997. Prostaglandin F2 -like compounds, F2 -isoprostanes, are present in increased amounts in human atherosclerotic lesions. Atheroscler Thromb Vasc Biol 17: 3236-3241.
7. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A. 2006. Free radicals, mitochondria, and oxidized lipids. The emerging role in signal transduction in vascular cells. Circ Res 99: 924-932.
8. Halliwell B, Gutteridge JMC. 2007. Free Radicals in Biology and Medicine, 4th ed., Oxford: Clarendon Press.
9. Jira W, Spiteller G, Carson W, Schramm A. 1998. Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem Phys Lipids 91: 1-11.
10. Kitano S, Yoshida Y, Kawano K, Hibi N, Niki E. 2007. Oxidative status of human low density lipotein isomated by anion -exchange high performance liquid chromatography: Assessment by total hydroxyoctadecadienoic acid. 7 -hydroxycholesterol, and 8 -isoprstaglandin F 2 a, Anal Chim Acta 585: 86-93.
11. Lee C-Y, Huang SH, Jenner AM, Halliwell B. 2008. Measurement of F 2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. Free Radic Biol Med 44: 1314-1322.
12. Leonarduzzi G, Arkan MC, Basaga H, Chiarpotto E, Sevanian A, Poli G. 2000. Lipid oxidation products in cell signaling. Free Radic Biol Med 28: 1370-1378.
13. Li L, Duker JS, Yoshida Y, Niki E, Rasmussen H, Russell RM, Yeum KJ, 2009. Oxidative stress and antioxidant status in older adults with early cataract. Eye 23: 1464-1468.
14. Montine T, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts II LJ, Morrow JD. 2002. Lipid peroxidation in aging brain and Alzheimer ' s disease. Free Radic Biol Med 33: 620-626.
15. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts II LJ. 1992. Non -cyclooxygenase -derived prostanoids (F 2 -isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89: 10721-10725.
16. Niki E, Yoshida Y, Saito Y, Noguchi N. 2005. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 338: 668-676.
17. Niki E, Omata Y, Fukuhara A, Saito Y, Yoshida Y. 2008. Assessment of radical scavenging capacity and lipid peroxidation inhibiting capacity. J Agric Food Chem 56: 8255-8260.
18. Noguchi N, Niki E. 1999. Chemistry of active oxygen species and antioxidants. In Antioxidant Status, Diet, Nutrition, and Health. Papas AM, ed. Boca Raton: CRC Press, pp. 3-20.
19. Omata Y, Saito Y, Yoshida Y, Niki E. 2008. Simple assessment of radical scavenging capacity of beverages. J Agric Food Chem 56: 3386-3390.
20. Panasenko OM, Vakhrusheva TV, Vlasova II, Chekanov AV, Baranov YV, Sergienko VI. 2007. Role of myeloperoxidase -mediated modification of human blood lipoproteins in atherosclerosis environment. Bull Exp Boil Med 144: 428-431.
21. Platico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, Fitzgerald GA. 1997. Localization of distinct F2 -isoprostanes in human atherosclerotic lesions. J Clin Invest 100: 2028-2034.
22. Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 2008. 4 -Hydroxynonenal: a membrane lipid oxidation products of medicinal interest. Medic Res Rev 28: 569-631.
23. Porter NA, Caldwell SE, Mills KA. 1995. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30: 277-290.
24. Prior RL, Wu X, Scaich K. 2005. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem 53: 4290-302.
25. Roberts II LJ, Fessel JP, Davies SS. 2005. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol 15: 143-148.
26. Schiller J, Sü R, Arnhold J, Fuchs B, Lessig J, Müller M, Petkovic M, Spalteholz H, Zschörnig O, Arnold K. 2004. Matrix -assisted laser desorption and ionization time -of -flight (MALDI -TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res 43: 449-488.
27. Schneider C, Pratt DA, Porter NA, Brash AR. 2007. Control of oxygenation in lipoxygenase catalysis. Chem Biol 14: 473-488.
28. Steinberg D, Parthasarathy S, Carew TE, Khoo JW, Witztum JL. 1989. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenicity. New Engl J Med 320: 915-924.
29. Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, Smith MA, Zhu X. 2008. Oxidative stress signaling in Alzheimer ' s disease. Curr Alzheimer Res 6: 525-532.
30. Tang DG, La E, Kern J, Kehrer LP. 2002. Fatty acid oxidation and signaling in apoptosis. Biol Chem 383: 425-442.
31. Terao K, Niki E. 1986. Damage to biological tissues induced by radical initiator 2,2 -azobis(2 -amidinopropane) dihydrochloride and its inhibition by chain breaking antioxidants. J Free Radic Biol Med 2: 193-201.
32. Yamamoto S. 1992. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128: 117-131.
33. Yamashita H, Nakamura A, Noguchi N, Niki E, Kuhn H. 1999. Oxidation of low density liporoprotein and plasma by 15 -lipoxygenase and free radicals. FEBS Lett 445: 287-290.
34. Yeum K -J, Russell RM, Krinsky NI, Aldini G. 2004. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys 430: 97-103.
35. Yoshida Y, Itoh N, Hayakawa M, Piga R, Cynshi O, Jishage K, Niki E. 2005a. Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE. Toxic Appl Pharmacol 208: 87-97.
36. Yoshida Y, Hayakawa M, Niki E. 2005b. Total hydroxyoctadecadienoic acid as a marker for lipid peroxidation in vivo. BioFactors 24: 7-15.
37. Yoshida Y, Hayakawa M, Habuchi Y, Niki E. 2006a. Evaluation of the dietary effects of coenzyme Q in vivo by the oxidative stress marker, hydroxyoctadecadienoic acid and its stereo isomer ratio. Biochim Biophys Acta 1760: 1558-1568.
38. Yoshida Y, Itoh N, Hayakawa M, Habuchi Y, Inoue R, Chen Z -H, Cao J, Cynshi O, Niki E. 2006b. Lipid peroxidation in mice fed a choline -deficient diet as evaluated by total hydroxyoctadecadienoic acid. Nutr 22: 303-311.
39. Yoshida Y, Saito Y, Hayakawa M, Habuchi Y, Imai Y, Sawai Y, Niki E. 2007a. Levels of lipid peroxidation in human plasma and erythrocytes: Comparison between fatty acids and cholesterol. Lipids 42: 439-449.
40. Yoshida Y, Hayakawa M, Habuchi Y, Itoh N, Niki E. 2007b. Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane. Lipids 42: 463-472.
41. Yoshida Y, Kodai S, Takemura S, Minamiyama Y, Niki E. 2008a. Simultaneous measurement of F 2 -isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal Biochem 379: 105-115.
42. Yoshida Y, Hayakawa M, Cynshi O, Jishage K, Niki E. 2008b. Acceleration of lipid peroxidation in a -tocopherol transfer protein -knock out mice following the consumption of drinking water containing a radical initiator. J Oleo Sci 57: 577-583.
43. Yoshida Y, Hayakawa M, Niki E. 2008c. Evaluation of the antioxidant effects of coffee and its components using the biomarkers hydroxyoctadecadienoic acid and isoprostane. J Oleo Sci 57: 691-697.
44. Yoshida Y, Yoshikawa A, Kinumi T, Ogawa Y, Saito Y, Ohara K, Yamamoto H, Imai Y, Niki E. 2009. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer ' s disease patients and their potential as biomarkers. Neurobiol Aging 30: 174-185.